🔗 Share this article

A shadow market for unapproved slimming medications is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.

Investigational Treatment Acquiring Traction Via Social Media

Retatrutide, which is still in clinical trials, is being promoted by online personalities for its alleged fat-burning effects. Followers are encouraged to contact these accounts directly for source information, while also obtaining promotional offers.

Thriving Commerce on Messaging Platforms

Separately, a robust trade exists on Telegram, where groups with thousands of members share comparison photos, injection guides and claims of next-day UK delivery. Vendors market the drug there before redirecting customers to WhatsApp for transactions.

Understanding Retatrutide

This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.

Medical Experts Express Concerns

However, doctors and chemists have cautions that the sale of what remains an unapproved drug in the UK is worrisome and could result in individuals administering products of unknown origin.

Some experts stated the popularity for retatrutide could be connected to the rising price of approved slimming products such as Mounjaro.

Legal Position and Enforcement

Selling the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unapproved drug that must not be marketed or supplied for human use under the Human Medicines Regulations 2012.

Several influencers try to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still breach pharmaceutical, marketing, and customer laws, potentially leading to penalties, prosecution or imprisonment.

Service Reaction and Material Removal

According to TikTok, the service has taken down violative content and prohibited related hashtags and query recommendations. The company said it was committed to maintaining the platform safe and allocating resources in enhancing enforcement strategies.

Online Trading Operations

Investigations also discovered groups with up to 9,000 participants selling the experimental drug using the platform's integrated search feature, which operates like a public directory. Typing “retatrutide” immediately brings up channels with thousands of users, filled with photos of weight loss, glowing testimonials and step-by-step guides for mixing or administering at home.

After minutes of entering one community, a vendor posted WhatsApp details, where the majority of purchases occur. The seller provided an guidebook and guaranteed shipping within 48 hours. When asked whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. None inquired about body mass, medical conditions or past usage.

Item Details and Costs

Inside these groups, messages display dark colored parcels with Royal Mail labels, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at residence with sterile water, or ready-to-use pens typically sold at £160 for 20 milligrams. When questioned how long a injector should be used, sellers give contradictory answers ranging from a few weeks to “depends on your body”.

Service Moderation and Security Measures

A spokesperson for Telegram said it regularly moderated dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are injecting materials they can’t verify. Even if the research behind this drug is sound, these online versions may not contain what they advertise,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor connected the surge in interest to recent cost increases for approved slimming medications such as Mounjaro. “With costs rising, patients are turning to social media. But counterfeit treatments are highly dangerous. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she explained.

Her team has already encountered individuals injured by personal administration from unverified sources. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be impure or improperly measured.”

Manufacturer Statement

A spokesperson from Eli Lilly said retatrutide was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may subject users to possibly serious medical dangers”.